Lucas M. Golem was appointed as Chief Accounting Officer at OMEGA HEALTHCARE INVESTORS INC.
“Lucas M. Golem, the Company’s Vice President of Financial Reporting, to succeed Mr. Ballew’s position and serve as the Company’s Chief Accounting Officer”
OMEGA HEALTHCARE INVESTORS INC — fact timeline
Source-grounded facts extracted from OMEGA HEALTHCARE INVESTORS INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Neal A. Ballew changed role as Chief Financial Officer at OMEGA HEALTHCARE INVESTORS INC.
“The Board also appointed Neal A. Ballew, the Company’s Senior Vice President and Chief Accounting Officer, to serve as the Company’s Chief Financial Officer”
Matthew P. Gourmand was appointed as President and Chief Executive Officer at OMEGA HEALTHCARE INVESTORS INC.
“The Board also appointed Matthew P. Gourmand, the Company’s President, to serve as the Company’s President and Chief Executive Officer, effective as of the CEO Transition Date.”
Robert O. Stephenson departed as Chief Financial Officer at OMEGA HEALTHCARE INVESTORS INC.
“on May 19, 2026, the Board and Robert O. Stephenson mutually agreed that Mr. Stephenson’s employment with the Company will terminate effective August 1, 2026”
C. Taylor Pickett departed as member of the Board at OMEGA HEALTHCARE INVESTORS INC.
“position as a member of the Board will terminate effective October 1, 2026”
C. Taylor Pickett departed as Chief Executive Officer at OMEGA HEALTHCARE INVESTORS INC.
“On May 19, 2026, the Board and C. Taylor Pickett, the Company’s Chief Executive Officer, mutually agreed that Mr. Pickett’s employment with the Company and position as a member of the Board will terminate effective October 1, 2026”
OMEGA HEALTHCARE INVESTORS INC reported the quarter ended March 31, 2026 results: net income $159 million, EPS $0.47 per diluted share. Guidance raised.
“(NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended March 31, 2026. FIRST QUARTER 2026 AND RECENT HIGHLIGHTS ● Net income for the quarter of $159 million, or $0.47 per diluted share, compared to $112 million, or $0.33 per diluted share, for Q1 2025. ● Adjusted Funds From Operations (“Adjusted FFO” or “AFFO”) for the quarter of”
OMEGA HEALTHCARE INVESTORS INC incurred senior notes of $600 million aggregate principal amount with U.S. Bank Trust Company, National Association at 5.200% per annum maturing July 1, 2030.
“completed an underwritten public offering of $600 million aggregate principal amount of its 5.200% Senior Notes due 2030”
Daniel J. Booth was terminated as Chief Operating Officer at OMEGA HEALTHCARE INVESTORS INC.
“the Company and Daniel J. Booth, the Company’s Chief Operating Officer, mutually agreed that Mr. Booth’s employment with the Company would terminate effective January 2, 2025.”
Vikas Gupta was appointed as Chief Investment Officer at OMEGA HEALTHCARE INVESTORS INC.
“the Board appointed Vikas Gupta, previously the Company’s Senior Vice President of Acquisitions & Development, as Chief Investment Officer of the Company.”
Matthew Gourmand was appointed as President at OMEGA HEALTHCARE INVESTORS INC.
“the Board of Directors (the “Board”) of Omega Healthcare Investors, Inc. (the “Company”) appointed Matthew Gourmand, previously the Company’s Senior Vice President of Corporate Strategy & Investor Relations, as President of the Company.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.